In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Bluebird bio Inc (NASDAQ: BLUE) closed the day trading at $4.08 down -42.05% from the previous closing price of $7.04. In other words, the price has decreased by -$42.05 from its previous closing price. On the day, 5.41 million shares were traded.
Ratios:
For a better understanding of BLUE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.33 and its Current Ratio is at 0.51.
On November 15, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $3 to $0.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 03 ’25 when Klima Thomas J sold 122 shares for $7.39 per share. The transaction valued at 902 led to the insider holds 8,378 shares of the business.
Colvin Richard A sold 64 shares of BLUE for $473 on Feb 03 ’25. The Chief Medical Officer now owns 8,194 shares after completing the transaction at $7.39 per share. On Feb 03 ’25, another insider, Vittiglio Joseph, who serves as the Chief Business & Legal Officer of the company, sold 238 shares for $7.39 each. As a result, the insider received 1,759 and left with 4,501 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.75.
Stock Price History:
Over the past 52 weeks, BLUE has reached a high of $38.40, while it has fallen to a 52-week low of $5.80. The 50-Day Moving Average of the stock is -47.59%, while the 200-Day Moving Average is calculated to be -68.87%.
Shares Statistics:
A total of 9.70M shares are outstanding, with a floating share count of 9.62M. Insiders hold about 1.13% of the company’s shares, while institutions hold 31.01% stake in the company.
